Close Menu

NEW YORK (GenomeWeb) – Cellular Dynamics will supply its iCell products for drug discovery to Roche and collaborate on identifying novel drug candidates, the company said today.

Under the terms of the agreement, Roche will have exclusive access to certain iCell products, derived from induced pluripotent stem cells (iPSCs), for use in high-throughput screening and lead optimization for drug discovery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.